Asbestos exposure predicts cell cycle control Gene promoter methylation in pleural mesothelioma
Date
2008-2-28
Authors
Christensen, Brock C.
Godleski, John J.
Marsit, Carmen J.
Houseman, E.A.
Lopez-Fagundo, Cristina Y.
Longacker, Jennifer L.
Bueno, Raphael
Sugarbaker, David J.
Nelson, Heather H.
Kelsey, Karl T.
Version
OA Version
Citation
Christensen, Brock C., John J. Godleski, Carmen J. Marsit, E. A. Houseman, Cristina Y. Lopez-Fagundo, Jennifer L. Longacker, Raphael Bueno, David J. Sugarbaker, Heather H. Nelson, Karl T. Kelsey. "Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma" Carcinogenesis 29(8): 1555-1559. (2008)
Abstract
Malignant pleural mesothelioma (MPM) is a rapidly fatal tumor with increasing incidence worldwide responsible for many thousands of deaths annually. Although there is a clear link between exposure to asbestos and mesothelioma, and asbestos is known to be both clastogenic and cytotoxic to mesothelial cells, the mechanisms of causation of MPM remain largely unknown. However, there is a rapidly emerging literature that describes inactivation of a diverse array of tumor suppressor genes (TSGs) via promoter DNA CpG methylation in MPM, although the etiology of these alterations remains unclear. We studied the relationships among promoter methylation silencing, asbestos exposure, patient demographics and tumor histology using a directed approach; examining six cell cycle control pathway TSGs in an incident case series of 70 MPMs. Promoter hypermethylation of APC, CCND2, CDKN2A, CDKN2B, HPPBP1 and RASSF1 were assessed. We observed significantly higher lung asbestos body burden if any of these cell cycle genes were methylated (P<0.02), and there was a significant trend of increasing asbestos body counts as the number of methylated cell cycle pathway genes increased from 0 to 1 to >1 (P<0.005). This trend of increasing asbestos body count and increasing number of methylated cell cycle pathway genes remained significant (P<0.05) after controlling for age, gender and tumor histology. These data suggest a novel tumorigenic mechanism of action of asbestos and may contribute to the understanding of precisely how asbestos exposure influences the etiology and clinical course of malignant mesothelioma.
Description
License
© Christensen et al., 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org